Newsroom

Bench to bedside and back: basic and clinical scientists team up on potential cancer treatment

April 26, 2016



When Dr. Jim Dimitroulakos’ team discovered that pairing high doses of cholesterol-lowering statins with cancer drug erlotinib enhanced its anti-cancer activity, they partnered with Dr. Glen Goss on a clinical trial to test the combination’s safety and efficacy. Their Phase I trial, published in the Journal of Translational Medicine, involved 24 cancer patients at The Ottawa Hospital who had exhausted all other treatment options. For a subset, their cancer did not progress for more than six months, a significant result for these end-stage patients. However, many of the participants suffered statin-induced muscle pains and weakness. These insights spurred further laboratory studies to identify ways to improve the therapy and reduce toxicity. This team is currently performing pre-clinical evaluations that may lead to a future clinical trial.

Authors: Goss GD, Jonker DJ, Laurie SA, Weberpals JI, Oza AM, Spaans JN, la Porte C, Dimitroulakos J.

Funders: Roche Canada, Canadian Institute of Health Research, Ontario Institute for Cancer Research- High Impact Clinical Trials, Prostate Cancer Fight Foundation

About The Ottawa Hospital


The Ottawa Hospital is one of Canada’s largest learning and research hospitals with over 1,100 beds, approximately 12,000 staff and an annual budget of over $1.2 billion. Our focus on research and learning helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital, affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care.

About the University of Ottawa


The University of Ottawa is home to over 50,000 students, faculty and staff, who live, work and study in both French and English. Our campus is a crossroads of cultures and ideas, where bold minds come together to inspire game-changing ideas. We are one of Canada’s top 10 research universities—our professors and researchers explore new approaches to today’s challenges. One of a handful of Canadian universities ranked among the top 200 in the world, we attract exceptional thinkers and welcome diverse perspectives from across the globe. www.uottawa.ca

For further information, please contact


Amelia Buchanan
Senior Communication Specialist
Ottawa Hospital Research Institute
Office: 613-798-5555 x 73687
Cell: 613-297-8315
ambuchanan@ohri.ca